Funds holding Aardvark Therapeutics Inc
ISIN US0029421007 · United States
- Fund holders
- 34
- Of which ETFs
- 8 26 other funds
- Value held
- ≈ 5.3M $ 5.2M $ · 100.5K €
- Share of capital
- 4.4 % of 21.9M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 408,670 | 2.4M $ | 0.00 % | 1.87 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 140,389 | 808.6K $ | 0.00 % | 0.64 % | as of Jun 30, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 89,124 | 513.4K $ | 0.01 % | 0.41 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 66,747 | 274.3K $ | 0.00 % | 0.30 % | as of May 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 64,981 | 267.1K $ | 0.00 % | 0.30 % | as of May 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 42,615 | 245.5K $ | 0.02 % | 0.19 % | as of Jun 30, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 24,000 | 138.2K $ | 0.09 % | 0.11 % | as of Jun 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 22,633 | 93K $ | 0.00 % | 0.10 % | as of May 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 22,439 | 92.2K $ | 0.06 % | 0.10 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 18,735 | 77K $ | 0.00 % | 0.09 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 15,483 | 63.6K $ | 0.00 % | 0.07 % | as of May 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 8,867 | 51.1K $ | 0.00 % | 0.04 % | as of Jun 30, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 7,980 | 46K $ | 0.01 % | 0.04 % | as of Jun 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 6,719 | 27.6K $ | 0.00 % | 0.03 % | as of May 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 4,951 | 28.5K $ | 0.00 % | 0.02 % | as of Jun 30, 2026 ↗ |
| Small Cap Index Fund VALIC Co I | 4,636 | 19.1K $ | 0.00 % | 0.02 % | as of May 31, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 4,479 | 18.4K $ | 0.01 % | 0.02 % | as of May 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 VALUE INDEX FUND VANGUARD SCOTTSDALE FUNDS | 4,264 | 17.5K $ | 0.00 % | 0.02 % | as of May 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 2,679 | 15.4K $ | 0.01 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust | 2,474 | 14.3K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| AQR Small Cap Multi-Style Fund AQR Funds | 1,503 | 8.7K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 1,472 | 6K $ | 0.00 % | 0.01 % | as of May 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 1,274 | 7.3K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 1,150 | 4.7K $ | 0.01 % | 0.01 % | as of May 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 804 | 3.3K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| SIIT EXTENDED MARKET INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 800 | 3.3K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 600 | 2.5K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 475 | 2K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 469 | 1.9K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 200 | 1.2K $ | 0.00 % | as of Jun 30, 2026 ↗ | |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 72 | 475.2 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 12 | 49.3 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 3 | 12.3 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 100.5K € | 0.12 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.12 % | as of Dec 31, 2025 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.09 % | as of Jun 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.06 % | as of May 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.02 % | as of Jun 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.01 % | as of Jun 30, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.01 % | as of May 31, 2026 ↗ |
| VIP Disciplined Small Cap Portfolio Variable Insurance Products Fund II | 0.01 % | as of Jun 30, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 0.01 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.01 % | as of Jun 30, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 33 | -44 | 971,699 | -40.2 % |
| 2026Q2 | 77 | -4 | 1,625,774 | +2.8 % |
| 2026Q1 | 81 | +11 | 1,581,640 | +76.9 % |
| 2025Q4 | 70 | +11 | 894,304 | +24.4 % |
| 2025Q3 | 59 | +51 | 718,794 | +337.9 % |
| 2025Q2 | 8 | 164,127 |
Institutional managers
75 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Decheng Capital LLC | 3,917,299 | 14.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,242,777 | 4.7M $ | as of Mar 31, 2026 |
| Laurion Capital Management LP | 1,034,459 | 3.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 792,571 | 3M $ | as of Mar 31, 2026 |
| Tetragon Partners GP Ltd | 316,621 | 1.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 309,449 | 1.2M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300,000 | 1.1M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 199,322 | 751.4K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 163,355 | 615.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 157,888 | 595.2K $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 134,495 | 507K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 98,334 | 370.7K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 88,599 | 334K $ | as of Mar 31, 2026 |
| Woodline Partners LP | 72,429 | 273.1K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 70,792 | 266.9K $ | as of Mar 31, 2026 |
| CANTOR FITZGERALD, L. P. | 66,682 | 251.4K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 46,265 | 174.4K $ | as of Mar 31, 2026 |
| Cresset Asset Management, LLC | 43,259 | 163.1K $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 33,684 | 127K $ | as of Mar 31, 2026 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 30,637 | 115.5K $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 29,320 | 110.5K $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 28,000 | 105.6K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 27,085 | 102 $ | as of Mar 31, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 27,000 | 101.8K $ | as of Mar 31, 2026 |
| Centiva Capital, LP | 24,782 | 93.4K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Aardvark Therapeutics Inc". https://titelia.com/en/stocks/aardvark-therapeutics-inc-US0029421007